2023
VISTA (PD-1H) Is a Crucial Immune Regulator to Limit Pulmonary Fibrosis.
Kim S, Adams T, Hu Q, Shin H, Chae G, Lee S, Sharma L, Kwon H, Lee F, Park H, Huh W, Manning E, Kaminski N, Sauler M, Chen L, Song J, Kim T, Kang M. VISTA (PD-1H) Is a Crucial Immune Regulator to Limit Pulmonary Fibrosis. American Journal Of Respiratory Cell And Molecular Biology 2023, 69: 22-33. PMID: 36450109, PMCID: PMC10324045, DOI: 10.1165/rcmb.2022-0219oc.Peer-Reviewed Original ResearchConceptsIdiopathic pulmonary fibrosisPulmonary fibrosisImmune regulatorsTherapeutic potentialHuman idiopathic pulmonary fibrosisCrucial immune regulatorsNovel immune regulatorPulmonary fibrosis micePulmonary fibrosis modelNovel therapeutic targetRole of VISTAWild-type littermatesMonocyte-derived macrophagesT lymphocyte lineageVISTA expressionIPF treatmentAntibody treatmentImmune landscapeFibrotic mediatorsLung fibrosisFibrosis miceInflammatory responseFibrosis modelMyeloid populationsTherapeutic targetIntra-Abdominal Cystic Lymphangiomas: The Vanderbilt Experience
Mede A, Chotai P, Huh W, Tan M. Intra-Abdominal Cystic Lymphangiomas: The Vanderbilt Experience. Journal Of Surgical Research 2023, 285: 197-204. PMID: 36696706, DOI: 10.1016/j.jss.2022.12.026.Peer-Reviewed Case Reports and Technical NotesConceptsAbdominal lymphangiomaSmall bowelExtensive local invasionTime of diagnosisDiagnosis of lymphangiomaInstitutional review boardVanderbilt experienceAbdominal painMultivisceral resectionMedian durationMost patientsClinical featuresFavorable prognosisRetrospective reviewCystic tumorHistopathologic characteristicsInstitution experienceSurgical excisionSymptomatic lesionsMean ageMural nodulesPreoperative imagingRare pathologyExcisional biopsyIncomplete excision
2021
Differential pre-malignant programs and microenvironment chart distinct paths to malignancy in human colorectal polyps
Chen B, Scurrah CR, McKinley ET, Simmons AJ, Ramirez-Solano MA, Zhu X, Markham NO, Heiser CN, Vega PN, Rolong A, Kim H, Sheng Q, Drewes JL, Zhou Y, Southard-Smith AN, Xu Y, Ro J, Jones AL, Revetta F, Berry LD, Niitsu H, Islam M, Pelka K, Hofree M, Chen JH, Sarkizova S, Ng K, Giannakis M, Boland GM, Aguirre AJ, Anderson AC, Rozenblatt-Rosen O, Regev A, Hacohen N, Kawasaki K, Sato T, Goettel JA, Grady WM, Zheng W, Washington MK, Cai Q, Sears CL, Goldenring JR, Franklin JL, Su T, Huh WJ, Vandekar S, Roland JT, Liu Q, Coffey RJ, Shrubsole MJ, Lau KS. Differential pre-malignant programs and microenvironment chart distinct paths to malignancy in human colorectal polyps. Cell 2021, 184: 6262-6280.e26. PMID: 34910928, PMCID: PMC8941949, DOI: 10.1016/j.cell.2021.11.031.Peer-Reviewed Original ResearchMeSH KeywordsAdaptive ImmunityAdenomaAdultAgedAnimalsCarcinogenesisCell DeathCell DifferentiationColonic PolypsColorectal NeoplasmsDisease ProgressionFemaleGene Expression Regulation, NeoplasticGene Regulatory NetworksGenetic HeterogeneityHumansMaleMiceMiddle AgedMutationNeoplastic Stem CellsReproducibility of ResultsRNA-SeqSingle-Cell AnalysisTumor MicroenvironmentConceptsHuman colorectal polypsColorectal cancerColorectal polypsPrevention of CRCMicrosatellite-unstable colorectal cancersUnstable colorectal cancersGastric metaplasiaImmune microenvironmentTumor cell differentiation statusImmune cellsPrecision surveillancePrecursor polypsSerrated polypsConventional adenomasStem cell propertiesMalignant progressionImmunogenic potentialPolypsTumor cellsTherapeutic insightsCell differentiation statusCellular originMetaplasiaAdenomasMolecular heterogeneitySupermeres are functional extracellular nanoparticles replete with disease biomarkers and therapeutic targets
Zhang Q, Jeppesen DK, Higginbotham JN, Graves-Deal R, Trinh VQ, Ramirez MA, Sohn Y, Neininger AC, Taneja N, McKinley ET, Niitsu H, Cao Z, Evans R, Glass SE, Ray KC, Fissell WH, Hill S, Rose KL, Huh WJ, Washington MK, Ayers GD, Burnette DT, Sharma S, Rome LH, Franklin JL, Lee YA, Liu Q, Coffey RJ. Supermeres are functional extracellular nanoparticles replete with disease biomarkers and therapeutic targets. Nature Cell Biology 2021, 23: 1240-1254. PMID: 34887515, PMCID: PMC8656144, DOI: 10.1038/s41556-021-00805-8.Peer-Reviewed Original ResearchConceptsSmall extracellular vesiclesTherapeutic targetExtracellular vesiclesHepatic lipidsCardiovascular diseaseCetuximab resistanceMultiple cancersAlzheimer's diseaseDiseaseLactate secretionDisease biomarkersBiomarkersExtracellular RNAIntense investigationHuman diseasesGreater uptakeVivoCancerSecretion
2020
Key histopathologic features in idiopathic noncirrhotic portal hypertension: an interobserver agreement study and proposal for diagnostic criteria
Liang J, Shi C, Dupont WD, Salaria SN, Huh WJ, Correa H, Roland JT, Perri RE, Washington MK. Key histopathologic features in idiopathic noncirrhotic portal hypertension: an interobserver agreement study and proposal for diagnostic criteria. Modern Pathology 2020, 34: 592-602. PMID: 32958831, DOI: 10.1038/s41379-020-00676-8.Peer-Reviewed Original ResearchConceptsIdiopathic noncirrhotic portal hypertensionObliterative portal venopathyNoncirrhotic portal hypertensionPortal hypertensionLiver biopsyDiagnostic criteriaInterobserver agreement studyHistologic featuresHistopathologic diagnostic criteriaOriginal pathologic diagnosisPractical diagnostic criteriaAgreement studyKey histopathologicPortal venopathyVein sclerosisHistologic predictorsClinicopathologic correlationHistologic diagnosisPathologic diagnosisHistologic assessmentExperienced hepatopathologistsClinical informationHypertensionBiopsyThree-tiered classificationNoggin regulates foregut progenitor cell programming and mis-expression leads to esophageal atresia
Pinzon-Guzman C, Sangadala S, Riera KM, Popova EY, Manning E, Huh WJ, Alexander MS, Shelton JS, Boden SD, Goldenring JR. Noggin regulates foregut progenitor cell programming and mis-expression leads to esophageal atresia. Journal Of Clinical Investigation 2020, 130: 4396-4410. PMID: 32427591, PMCID: PMC7410075, DOI: 10.1172/jci123597.Peer-Reviewed Original ResearchDistribution of duodenal tuft cells is altered in pediatric patients with acute and chronic enteropathy
Huh WJ, Roland JT, Asai M, Kaji I. Distribution of duodenal tuft cells is altered in pediatric patients with acute and chronic enteropathy. Biomedical Research 2020, 41: 113-118. PMID: 32307399, PMCID: PMC10037909, DOI: 10.2220/biomedres.41.113.Peer-Reviewed Original ResearchConceptsTuft cell numbersIntestinal tuft cellsTuft cellsAcute duodenitisPediatric patientsCeliac diseaseAge-matched normal controlsDouble-blind conditionsCell numberDuodenal ulcerSevere inflammationMucosal integrityPathological diagnosisDuodenal mucosaNormal controlsPathological specimensUseful markerInflammationNormal tissuesPatientsHuman intestineClinical interestPathological conditionsDuodenitisUlcersThe Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution
Rozenblatt-Rosen O, Regev A, Oberdoerffer P, Nawy T, Hupalowska A, Rood J, Ashenberg O, Cerami E, Coffey R, Demir E, Ding L, Esplin E, Ford J, Goecks J, Ghosh S, Gray J, Guinney J, Hanlon S, Hughes S, Hwang E, Iacobuzio-Donahue C, Jané-Valbuena J, Johnson B, Lau K, Lively T, Mazzilli S, Pe’er D, Santagata S, Shalek A, Schapiro D, Snyder M, Sorger P, Spira A, Srivastava S, Tan K, West R, Williams E, Network H, Aberle D, Achilefu S, Ademuyiwa F, Adey A, Aft R, Agarwal R, Aguilar R, Alikarami F, Allaj V, Amos C, Anders R, Angelo M, Anton K, Ashenberg O, Aster J, Babur O, Bahmani A, Balsubramani A, Barrett D, Beane J, Bender D, Bernt K, Berry L, Betts C, Bletz J, Blise K, Boire A, Boland G, Borowsky A, Bosse K, Bott M, Boyden E, Brooks J, Bueno R, Burlingame E, Cai Q, Campbell J, Caravan W, Cerami E, Chaib H, Chan J, Chang Y, Chatterjee D, Chaudhary O, Chen A, Chen B, Chen C, Chen C, Chen F, Chen Y, Chheda M, Chin K, Chiu R, Chu S, Chuaqui R, Chun J, Cisneros L, Coffey R, Colditz G, Cole K, Collins N, Contrepois K, Coussens L, Creason A, Crichton D, Curtis C, Davidsen T, Davies S, de Bruijn I, Dellostritto L, De Marzo A, Demir E, DeNardo D, Diep D, Ding L, Diskin S, Doan X, Drewes J, Dubinett S, Dyer M, Egger J, Eng J, Engelhardt B, Erwin G, Esplin E, Esserman L, Felmeister A, Feiler H, Fields R, Fisher S, Flaherty K, Flournoy J, Ford J, Fortunato A, Frangieh A, Frye J, Fulton R, Galipeau D, Gan S, Gao J, Gao L, Gao P, Gao V, Geiger T, George A, Getz G, Ghosh S, Giannakis M, Gibbs D, Gillanders W, Goecks J, Goedegebuure S, Gould A, Gowers K, Gray J, Greenleaf W, Gresham J, Guerriero J, Guha T, Guimaraes A, Guinney J, Gutman D, Hacohen N, Hanlon S, Hansen C, Harismendy O, Harris K, Hata A, Hayashi A, Heiser C, Helvie K, Herndon J, Hirst G, Hodi F, Hollmann T, Horning A, Hsieh J, Hughes S, Huh W, Hunger S, Hwang S, Iacobuzio-Donahue C, Ijaz H, Izar B, Jacobson C, Janes S, Jané-Valbuena J, Jayasinghe R, Jiang L, Johnson B, Johnson B, Ju T, Kadara H, Kaestner K, Kagan J, Kalinke L, Keith R, Khan A, Kibbe W, Kim A, Kim E, Kim J, Kolodzie A, Kopytra M, Kotler E, Krueger R, Krysan K, Kundaje A, Ladabaum U, Lake B, Lam H, Laquindanum R, Lau K, Laughney A, Lee H, Lenburg M, Leonard C, Leshchiner I, Levy R, Li J, Lian C, Lim K, Lin J, Lin Y, Liu Q, Liu R, Lively T, Longabaugh W, Longacre T, X. C, Macedonia M, Madison T, Maher C, Maitra A, Makinen N, Makowski D, Maley C, Maliga Z, Mallo D, Maris J, Markham N, Marks J, Martinez D, Mashl R, Masilionais I, Mason J, Massagué J, Massion P, Mattar M, Mazurchuk R, Mazutis L, Mazzilli S, McKinley E, McMichael J, Merrick D, Meyerson M, Miessner J, Mills G, Mills M, Mondal S, Mori M, Mori Y, Moses E, Mosse Y, Muhlich J, Murphy G, Navin N, Nawy T, Nederlof M, Ness R, Nevins S, Nikolov M, Nirmal A, Nolan G, Novikov E, Oberdoerffer P, O’Connell B, Offin M, Oh S, Olson A, Ooms A, Ossandon M, Owzar K, Parmar S, Patel T, Patti G, Pe’er D, Pe'er I, Peng T, Persson D, Petty M, Pfister H, Polyak K, Pourfarhangi K, Puram S, Qiu Q, Quintanal-Villalonga Á, Raj A, Ramirez-Solano M, Rashid R, Reeb A, Regev A, Reid M, Resnick A, Reynolds S, Riesterer J, Rodig S, Roland J, Rosenfield S, Rotem A, Roy S, Rozenblatt-Rosen O, Rudin C, Ryser M, Santagata S, Santi-Vicini M, Sato K, Schapiro D, Schrag D, Schultz N, Sears C, Sears R, Sen S, Sen T, Shalek A, Sheng J, Sheng Q, Shoghi K, Shrubsole M, Shyr Y, Sibley A, Siex K, Simmons A, Singer D, Sivagnanam S, Slyper M, Snyder M, Sokolov A, Song S, Sorger P, Southard-Smith A, Spira A, Srivastava S, Stein J, Storm P, Stover E, Strand S, Su T, Sudar D, Sullivan R, Surrey L, Suvà M, Tan K, Terekhanova N, Ternes L, Thammavong L, Thibault G, Thomas G, Thorsson V, Todres E, Tran L, Tyler M, Uzun Y, Vachani A, Van Allen E, Vandekar S, Veis D, Vigneau S, Vossough A, Waanders A, Wagle N, Wang L, Wendl M, West R, Williams E, Wu C, Wu H, Wu H, Wyczalkowski M, Xie Y, Yang X, Yapp C, Yu W, Yuan Y, Zhang D, Zhang K, Zhang M, Zhang N, Zhang Y, Zhao Y, Zhou D, Zhou Z, Zhu H, Zhu Q, Zhu X, Zhu Y, Zhuang X. The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution. Cell 2020, 181: 236-249. PMID: 32302568, PMCID: PMC7376497, DOI: 10.1016/j.cell.2020.03.053.Commentaries, Editorials and LettersConceptsSingle-cell genomic technologiesSingle-cell resolutionDynamic tumor ecosystemRelevant cell typesGenomic approachesCell statesGenomic technologiesTumor ecosystemBulk sequencingThree-dimensional atlasesCancer biologyCell typesCellular interactionsTumor initiationUnprecedented resolutionTumor transitionTherapeutic discoveryDiverse setCancer transitionComplex interactionsPrecision medicine treatmentBiologyCrucial transitionEcosystemsSequencing
2017
In liver metastases from small intestinal neuroendocrine tumors, SSTR2A expression is heterogeneous
Charoenpitakchai M, Liu E, Zhao Z, Koyama T, Huh WJ, Berlin J, Hande K, Walker R, Shi C. In liver metastases from small intestinal neuroendocrine tumors, SSTR2A expression is heterogeneous. Virchows Archiv 2017, 470: 545-552. PMID: 28213807, PMCID: PMC5623953, DOI: 10.1007/s00428-017-2093-3.Peer-Reviewed Original ResearchConceptsSmall intestinal neuroendocrine tumorsLiver metastasesSSTR2A expressionIntestinal neuroendocrine tumorsKi67 indexNeuroendocrine tumorsPrimary tumorLiver tumorsMetastatic small intestinal neuroendocrine tumorsMore liver lesionsMost liver tumorsCorresponding liver metastasesMore liver tumorsFormalin-fixed paraffin-embedded sectionsParaffin-embedded sectionsMetastatic lesionsMetastatic tumorsSI-NETsSame patientLiver lesionsIHC scoreMetastasisScoring systemSignificant associationTumor tissue
2016
Micropapillary colorectal carcinoma: clinical, pathological and molecular properties, including evidence of epithelial–mesenchymal transition
Gonzalez RS, Huh WJ, Cates JM, Washington K, Beauchamp RD, Coffey RJ, Shi C. Micropapillary colorectal carcinoma: clinical, pathological and molecular properties, including evidence of epithelial–mesenchymal transition. Histopathology 2016, 70: 223-231. PMID: 27560620, PMCID: PMC5921077, DOI: 10.1111/his.13068.Peer-Reviewed Original ResearchConceptsEpithelial-mesenchymal transitionColorectal carcinomaDistant metastasisImmunohistochemical evidenceEvidence of EMTAdvanced T categoryConventional colorectal carcinomaCystic nodal metastasisStage IV diseaseAdvanced local diseaseLymph node metastasisMicrosatellite instability testingBRAF V600E mutationMedian survivalMucinous featuresOverall survivalNodal metastasisNode metastasisLocal diseaseMicropapillary featuresT categoryDirty necrosisCribriform patternKRAS mutationsProminent necrosisThe Spectrum of Histologic Findings in Hepatic Outflow Obstruction
Gonzalez RS, Gilger MA, Huh WJ, Washington MK. The Spectrum of Histologic Findings in Hepatic Outflow Obstruction. Archives Of Pathology & Laboratory Medicine 2016, 141: 98-103. PMID: 27681331, PMCID: PMC6420777, DOI: 10.5858/arpa.2015-0388-oa.Peer-Reviewed Original ResearchConceptsHepatic outflow obstructionPortal tract changesCardiac hepatopathyBudd-Chiari syndromeOutflow obstructionHistologic findingsBudd-ChiariSinusoidal fibrosisSinusoidal dilationTract changesCentral veinHepatic venous outflow obstructionVenous outflow obstructionBile ductular reactionDistinctive histologic findingsHepatocyte dropoutDifferent pathophysiologyPrior diagnosisChronic inflammationCentrilobular necrosisDuctular reactionMorphologic findingsUndiagnosed patientsChronic natureHepatopathyHepatocyte nuclear factor 4α is required for cell differentiation and homeostasis in the adult mouse gastric epithelium
Moore BD, Khurana SS, Huh WJ, Mills JC. Hepatocyte nuclear factor 4α is required for cell differentiation and homeostasis in the adult mouse gastric epithelium. AJP Gastrointestinal And Liver Physiology 2016, 311: g267-g275. PMID: 27340127, PMCID: PMC5007292, DOI: 10.1152/ajpgi.00195.2016.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsBasic Helix-Loop-Helix Transcription FactorsBinding SitesCell DifferentiationCell LineCell ProliferationEpithelial CellsGastric MucosaGene Expression RegulationGenotypeHepatocyte Nuclear Factor 4HomeostasisHumansMice, KnockoutPhenotypePromoter Regions, GeneticSignal TransductionTransfectionX-Box Binding Protein 1ConceptsZymogenic chief cellsAdult mouse stomachX-box binding protein 1Gastric unitsRole of HNF4αStem cell zoneHepatocyte nuclear factor 4 alphaLoss of HNF4αBinding protein 1Nuclear factor 4 alphaHepatocyte nuclear factor 4αHuman gastric cancer cellsMouse stomachTranscriptional regulatorsChromatin immunoprecipitationNuclear factor 4αGastric cancer cellsXBP1 mRNAHNF4α proteinTranscription factorsUpstream regulationMouse gastric epitheliumHuman gastric cellsCell differentiationAdditional phenotypes
2013
Chronic Tamoxifen Use Is Associated with a Decreased Risk of Intestinal Metaplasia in Human Gastric Epithelium
Moon CM, Kim SH, Lee SK, Hyeon J, Koo JS, Lee S, Wang JS, Huh WJ, Khurana SS, Mills JC. Chronic Tamoxifen Use Is Associated with a Decreased Risk of Intestinal Metaplasia in Human Gastric Epithelium. Digestive Diseases And Sciences 2013, 59: 1244-1254. PMID: 24368421, PMCID: PMC4035390, DOI: 10.1007/s10620-013-2994-1.Peer-Reviewed Original ResearchConceptsRisk of IMTamoxifen useEndoscopic gastroduodenoscopyDecreased riskGastric cancerFemale breast cancer patientsMultivariate logistic regression analysisHuman stomachHelicobacter pylori positivityBreast cancer patientsEffect of tamoxifenLogistic regression analysisHuman gastric epitheliumClinical characteristicsPylori positivityHistopathological findingsIntestinal metaplasiaPredictive factorsSydney classificationBreast surgeryCancer patientsGastric biopsiesPremalignant lesionsEstrogen exposureBiopsy siteEvolution of the human gastrokine locus and confounding factors regarding the pseudogenicity of GKN3
Geahlen JH, Lapid C, Thorell K, Nikolskiy I, Huh WJ, Oates EL, Lennerz JK, Tian X, Weis VG, Khurana SS, Lundin SB, Templeton AR, Mills JC. Evolution of the human gastrokine locus and confounding factors regarding the pseudogenicity of GKN3. Physiological Genomics 2013, 45: 667-683. PMID: 23715263, PMCID: PMC3742967, DOI: 10.1152/physiolgenomics.00169.2012.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsCarrier ProteinsComputational BiologyDNA PrimersEvolution, MolecularFluorescent Antibody TechniqueGastric MucosaGenetic LociGenetics, PopulationGenotypeHaplotypesHumansLikelihood FunctionsMacaca mulattaMembrane ProteinsMiceMice, Inbred C57BLMicroarray AnalysisMicroscopy, ConfocalModels, GeneticMutationPhylogenyPolymorphism, Single NucleotidePseudogenesRacial GroupsSelection, GeneticSpecies SpecificitySus scrofaConceptsSelective sweepsHuman genetic locusGenome evolutionGenomic neighborsSplice donor siteDirectional selectionHuman genomeGenetic lociBp downstreamEuropean genesGKN3Gastric mucous neck cellsStop codon mutationThird memberHuman populationGenesCodon mutationLociGKN2Haplotype analysisMucous neck cellsMutationsAfrican populationsNeck cellsGKN1
2010
The Transcription Factor MIST1 Is a Novel Human Gastric Chief Cell Marker Whose Expression Is Lost in Metaplasia, Dysplasia, and Carcinoma
Lennerz JK, Kim SH, Oates EL, Huh WJ, Doherty JM, Tian X, Bredemeyer AJ, Goldenring JR, Lauwers GY, Shin YK, Mills JC. The Transcription Factor MIST1 Is a Novel Human Gastric Chief Cell Marker Whose Expression Is Lost in Metaplasia, Dysplasia, and Carcinoma. American Journal Of Pathology 2010, 177: 1514-1533. PMID: 20709804, PMCID: PMC2928982, DOI: 10.2353/ajpath.2010.100328.Peer-Reviewed Original ResearchConceptsChief cellsTranscription factor MIST1Gastric carcinogenesisMIST1 expressionSimilar progressive lossChief cell lineagesNormal oxyntic mucosaHuman gastric carcinogenesisHuman chief cellsChief cell markersIntestinal metaplasiaCell carcinomaMetaplastic lesionsResection specimensGastric adenocarcinomaPrecursor lesionsOxyntic mucosaTissue microarrayMetaplasiaMurine dataReliable markerTFF2 expressionHuman lesionsCell markersComparison of findings
2009
How form follows functional genomics: gene expression profiling gastric epithelial cells with a particular discourse on the parietal cell
Capoccia BJ, Huh WJ, Mills JC. How form follows functional genomics: gene expression profiling gastric epithelial cells with a particular discourse on the parietal cell. Physiological Genomics 2009, 37: 67-78. PMID: 19208773, PMCID: PMC2685495, DOI: 10.1152/physiolgenomics.90408.2008.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsFunctional genomic studiesFunctional genomicsGene expressionGenomic studiesCell lineagesEntire cellular transcriptomeGene ontology analysisDifferentiated cell lineagesGene expression patternsCellular transcriptomeParietal cellsVascular endothelial growth factor BIndividual genesLineage-specific markersOntology analysisCell physiologyGene productsMolecular anatomyGastric parietal cellsExpression patternsMicroarray analysisMolecular mechanismsCell-specific markersGastric epithelial cellsGrowth factor B
2006
Location, allocation, relocation: isolating adult tissue stem cells in three dimensions
Huh WJ, Pan XO, Mysorekar IU, Mills JC. Location, allocation, relocation: isolating adult tissue stem cells in three dimensions. Current Opinion In Biotechnology 2006, 17: 511-517. PMID: 16889955, DOI: 10.1016/j.copbio.2006.07.002.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements